Codex DNA, Inc. announced revenue guidance for the full year 2022. For the year, the company expected Total Revenue in the range of $19 million to $21 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.45 USD | -2.54% | -23.33% | -51.96% |
05-09 | Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M | MT |
05-09 | Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.96% | 5.77M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.05% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- TBIO Stock
- News Telesis Bio, Inc.
- Codex DNA, Inc. Announces Revenue Guidance for the Full Year 2022